Injectable Submental Fat Treatment
Have you been struggling to reduce the size of a double chin? Stubborn submental fat along the underside of the chin is a common problem for many men and women–even despite healthy diet and exercise. While facial liposuction can be an effective option to sculpt this lower portion of the face, many of our patients come to our Seattle plastic surgery practice looking for a less-invasive option. For this, we recommend Kybella.
Actual patient of Dr. Patel
What is Kybella?
Kybella is a non-surgical way to reduce problem fat cells that can often linger beneath the chin and jawline–sometimes giving off the appearance of a “double chin.” This injectable procedure uses an active ingredient known as deoxycholic acid, which is FDA approved for the treatment of submental fat cells. Once injected beneath the skin, the deoxycholic acid causes the targeted fat cells to deactivate and ultimately be flushed from your body. The end result is a slimmer, well-contoured facial profile and chin.
How does Kybella treat excess chin fat?
This injectable fat reduction treatment is performed in-office at the Larrabee Center for Plastic Surgery in Seattle. Dr’s. Wayne Larrabee will carefully analyze your current condition and listen to your expectations to help determine if Kybella is right for you. Alternative treatments include facial liposuction, with which Dr’s. Larrabee can also help achieve natural-looking outcomes.
During your Kybella treatment, our nurse injectors will mark the targeted injection sites beneath the chin using a specially designed template. This will ensure an even and natural-looking reduction of the unwanted fat. With each injection, a small amount of Kybella will be administered into the underlying fat cells, causing them to gradually “shut off” and be naturally flushed from your body.
Dr’s. Larrabee often recommend a series of multiple Kybella treatment sessions to achieve optimal results. This will be based on the amount of fat you are looking to treat, as well as your desired outcome.